Hepatocellular carcinoma patients undergoing transarterial chemoembolization Discharge Planning, Transarterial Chemoembolization, Hepatocellular Carcinoma, Fatigue, Functional Status
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Hepatocellular carcinoma patients undergoing transarterial chemoembolization first time or second time. 2. Patients can communicate in Thai and understand. 3. Patients above 60 years of age with a cognitive score from a casual Thai Mental State Examination score is greater than or equal to 23 points 4. Patients must be able to be reached by phone.
Exclusion criteria
Exclusion criteria: 1. Patients have a history of diagnosis of all kinds of psychiatric disorders 2. Stage of disease BCLC level D 3. ECOG Score more than 2 4. Received Combined TACE and RFA treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue the day after treatment transarterial chemoembolization (TACE) day 0, 1, 3, 7, 14 and 30. The fatigue severity scale (FFS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional status the day after treatment transarterial chemoembolization (TACE) day 7, 14 and 30. Enforced Social Dependency Scale (ESDS) | — |
Countries
Thailand
Contacts
Faculty of Nursing, Mahidol University